GENETIC TESTING for HEREDITARY CANCER SYNDROMES Resource Guide
Patient Risk Assessment Bracanalysis Colaris Melaris Colaris AP The Testing Process Billing and Insurance Outreach Materials Clinical References and Resources



p16 GENE

Also known as CDKN2A, INK4A, or MTS1, the p16 gene is located on chromosome 9p21 and accounts for approximately 20%-40% of hereditary melanoma cases. p16 is a tumor suppressor gene that regulates cellular proliferation and growth by acting as a cyclin-dependent kinase 4 (CDK4) inhibitor.


The p16 gene controls cellular proliferation and growth.

As such, a mutation in either copy of the gene can act to disrupt normal gene function leading to unregulated cell growth. The p16 gene is composed of three exons (471 base pairs) that encodes a 156 amino acid protein. Mutations are found to occur within the coding sequence, splicing, and promoter regions of the gene. While the p16 gene accounts for the majority of known genetic causes of inherited melanoma cases, other genes such as CDK4 and p14ARF may account for a handful (<1%) of hereditary melanoma cases. Unknown or as yet unidentified genes account for the remainder of hereditary melanoma cases.

» More



© 2004-06, Myriad Genetic Laboratories, Inc.

Introduction
Informed Consent Case Study
Want to know more?
Background
p16 Gene
Cancer Risk
Testing Guidelines
Test Results and Medical Management